{
  "created_at": "2019-05-26T15:34:27.000Z",
  "updated_at": "2021-01-06T08:24:39.193Z",
  "id": "458846dd-aea3-4df1-a60b-5b36cb21f0be",
  "labels": "current-affairs,2019-05-27",
  "question": "Consider the following statements regarding the new LDL â€“ Cholesterol drugs 1. It is expected to lower the cholesterol by 75%. 2. They are given twice a year instead of monthly or weekly like other treatments. Which of the above statements is/are correct?",
  "option1": "1 only",
  "option2": "2 only",
  "option3": "Both 1 and 2",
  "option4": "Neither 1 nor 2",
  "option5": "",
  "answer": "Both 1 and 2",
  "explanation": "Statement 1 is correct: There is a new class of LDL cholesterol-lowering drugs that are expected to be disruptors in the next year. The new drugs are expected to lower cholesterol to unprecedented levels. When taken with a Statin cholesterol-lowering drug, the new class of drugs is expected to lower cholesterol levels by 75%. Statement 2 is correct: The small interfering RNA therapy to lower LDL was also an innovation in 2017. They are given twice a year instead of monthly or weekly like other treatments."
}